2023-2024 Updated Vaccine
Now Available in the U.S.

Information about our vaccine for Healthcare Professionals

Please visit our authorization website for healthcare professionals for information on vial expiration dates, efficacy, safety, and other resources. 

Needle icon

Latest press release on vaccine candidates

COVID-19 vaccine research updates

Novavax COVID-19 vaccine (recombinant, adjuvanted) is now conditionally authorized in several regions

Novavax information for:


Novavax Announces Launch of Choose to Protect Campaign

Choose to Protect

Current Protocol for Phase 3 Clinical Trial of NVX-CoV2373 in the U.S. and Mexico

Novavax's Investor Hub

Visit our Investor Hub to access investor resources and information on upcoming and past events. Sign up to receive notifications for investor updates, such as upcoming events and webcasts, daily closing stock price, SEC filings, and press releases.

Latest quarterly earnings
Latest investor presentation
2022 annual report
Loading data...

Explore current opportunities in:


What is a protein-based vaccine?

Science & technology

Our pipeline—creating tomorrow's vaccines today

Who we are

Novavax is powered by global collaborations